Return to home page
Searching: Otterbein library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title Clinical trials of genetic therapy with antisense DNA and DNA vectors / edited by Eric Wickstrom.
Imprint New York, N.Y. : M. Dekker, 1998.

View online
View online
Subject Gene therapy -- Testing.
Antisense DNA -- Therapeutic use -- Testing.
Genetic vectors -- Therapeutic use -- Testing.
Clinical trials.
Genetic Therapy.
DNA, Antisense.
Genetic Vectors.
Clinical Trials.
Alt Name Wickstrom, Eric.
Description 1 online resource (xvii, 427 pages) : illustrations
Bibliography Note Includes bibliographical references and index.
Note Print version record.
ISBN 0585344469 (electronic bk.)
9780585344461 (electronic bk.)
0824700856 (acid-free paper)
OCLC # 47011686
Additional Format Print version: Clinical trials of genetic therapy with antisense DNA and DNA vectors. New York, N.Y. : M. Dekker, 1998 0824700856 (DLC) 98013317 (OCoLC)38439246
Table of Contents
 Foreword: Genetic Therapy in the 21st Century / O. Michael Colvin 
 Preface: From Theory to Practice in Thirty Years / Eric Wickstrom 
1A Brief History of Genetic Therapy: Gene Therapy, Antisense Technology, and Genomics / James W. Hawkins1
2Preclinical Development of Antisense Oligonucleotide Therapeutics for Cancer: Regulatory Aspects / Chang-Ho Ahn, Joseph J. DeGeorge39
3Commercial Scale Manufacturing of Oligonucleotides Under Good Manufacturing Practices / Jose E. Gonzalez, Richard G. Einig, Patricia Puma [et al.]53
4The Regulatory Process and Gene Therapy / Suzanne L. Epstein89
5Production of Clinical Lots of Gene Therapy Vectors Using Good Manufacturing Practice: Experience in a University Setting / Alan R. Davis, Colleen Baker101
6Gene Therapy Clinical Trials for Adenosine Deaminase Deficiency/Severe Combined Immunodeficiency / Erlinda M. Gordon, W. French Anderson111
7Development of an Oligodeoxynucleotide Pharmaceutical for the Treatment of Human Leukemia / Alan M. Gewirtz, Deborah Lee Sokol133
8Clinical Trials with Anti-p53 DNA, OL(1)p53, in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome / Patrick L. Iversen155
9Human Bcl-2 Antisense Therapy for Lymphomas / Finbarr E. Cotter, Andrew Webb, Paul Clarke [et al.]169
10Retroviral Gene Transfer in Autologous Bone Marrow and Stem Cell Transplantation / Rafat Abonour, Kenneth Cornetta191
11Adenoviral Gene Transfer of the Herpes Virus Thymidine Kinase Gene for Treating Gliomas / Jane B. Alavi, Jason G. Smith, Stephen L. Eck219
12Distribution and Toxicity of Retroviral Vectors After Intracavitary Delivery in Mouse and Man / Patrice S. Obermiller, Anne M. Pilaro, Carlos L. Arteaga [et al.]239
13Clinical and Immunologic Responses to Gene Transfer of an Allogeneic Major Histocompatibility Complex Antigen / Alison T. Stopeck, Evan M. Hersh257
14Defective Tumor Suppressor Gene Replacement and Oncogene Inactivation for the Treatment of Cancer / Jack Roth279
15The Molecular Basis of Bladder Cancer and Prospects for Gene Therapy Using Hammerhead Ribozymes / Eric J. Small, Mohammed Kashani-Sabet, David Y. Bouffard [et al.]295
16In Situ Gene Insertion for Immunotherapy Using Vaccinia Virus Vectors / Edmund C. Lattime, Laurence C. Eisenlohr, Michael J. Mastrangelo311
17Antisense Oligonucleotide-Based Therapy for HIV-1 Infection from Laboratory to Clinical Trials / Sudhir Agrawal331
18Treatment of Retinitis Induced by Cytomegalovirus Using Intravitreal Fomivirsen (Isis 2922) / Stanley T. Crooke353
19Synthetic DNA-Based Compounds for the Prevention of Coronary Restenosis: Current Status and Future Challenges / Andrew Zalewski, Yi Shi, John D. Mannion [et al.]363
20Prevention of Restenosis by Gene Targeting / Michael J. Mann, Heiko E. Von der Leyen, Victor J. Dzau395

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team